134 related articles for article (PubMed ID: 17455342)
21. Impact of polymers on the crystallization and phase transition kinetics of amorphous nifedipine during dissolution in aqueous media.
Raina SA; Alonzo DE; Zhang GG; Gao Y; Taylor LS
Mol Pharm; 2014 Oct; 11(10):3565-76. PubMed ID: 25185035
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the molecular distribution of drugs in glassy solid dispersions at the nano-meter scale, using differential scanning calorimetry and gravimetric water vapour sorption techniques.
van Drooge DJ; Hinrichs WL; Visser MR; Frijlink HW
Int J Pharm; 2006 Mar; 310(1-2):220-9. PubMed ID: 16427226
[TBL] [Abstract][Full Text] [Related]
23. Solubility of crystalline organic compounds in high and low molecular weight amorphous matrices above and below the glass transition by zero enthalpy extrapolation.
Amharar Y; Curtin V; Gallagher KH; Healy AM
Int J Pharm; 2014 Sep; 472(1-2):241-7. PubMed ID: 24968139
[TBL] [Abstract][Full Text] [Related]
24. Prediction of the onset of crystallization of amorphous sucrose below the calorimetric glass transition temperature from correlations with mobility.
Bhugra C; Rambhatla S; Bakri A; Duddu SP; Miller DP; Pikal MJ; Lechuga-Ballesteros D
J Pharm Sci; 2007 May; 96(5):1258-69. PubMed ID: 17455303
[TBL] [Abstract][Full Text] [Related]
25. An investigation of nifedipine miscibility in solid dispersions using Raman spectroscopy.
Keratichewanun S; Yoshihashi Y; Sutanthavibul N; Terada K; Chatchawalsaisin J
Pharm Res; 2015 Jul; 32(7):2458-73. PubMed ID: 25673042
[TBL] [Abstract][Full Text] [Related]
26. Correlation between molecular mobility and crystal growth of amorphous phenobarbital and phenobarbital with polyvinylpyrrolidone and L-proline.
Korhonen O; Bhugra C; Pikal MJ
J Pharm Sci; 2008 Sep; 97(9):3830-41. PubMed ID: 18200526
[TBL] [Abstract][Full Text] [Related]
27. Influence of copolymer composition on the phase behavior of solid dispersions.
Prudic A; Kleetz T; Korf M; Ji Y; Sadowski G
Mol Pharm; 2014 Nov; 11(11):4189-98. PubMed ID: 25295846
[TBL] [Abstract][Full Text] [Related]
28. Effect of physical properties of troglitazone crystal on the molecular interaction with PVP during heating.
Hasegawa S; Furuyama N; Yada S; Hamaura T; Kusai A; Yonemochi E; Terada K
Int J Pharm; 2007 May; 336(1):82-9. PubMed ID: 17178201
[TBL] [Abstract][Full Text] [Related]
29. Recrystallization of nifedipine and felodipine from amorphous molecular level solid dispersions containing poly(vinylpyrrolidone) and sorbed water.
Marsac PJ; Konno H; Rumondor AC; Taylor LS
Pharm Res; 2008 Mar; 25(3):647-56. PubMed ID: 17846870
[TBL] [Abstract][Full Text] [Related]
30. Origin of Nanodroplet Formation Upon Dissolution of an Amorphous Solid Dispersion: A Mechanistic Isotope Scrambling Study.
Indulkar AS; Waters JE; Mo H; Gao Y; Raina SA; Zhang GGZ; Taylor LS
J Pharm Sci; 2017 Aug; 106(8):1998-2008. PubMed ID: 28431965
[TBL] [Abstract][Full Text] [Related]
31. The stability of solid dispersions of felodipine in polyvinylpyrrolidone characterized by nanothermal analysis.
Zhang J; Bunker M; Parker A; Madden-Smith CE; Patel N; Roberts CJ
Int J Pharm; 2011 Jul; 414(1-2):210-7. PubMed ID: 21627985
[TBL] [Abstract][Full Text] [Related]
32. Crystal growth formation in melt extrudates.
Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
[TBL] [Abstract][Full Text] [Related]
33. Phase transformations undergone by Triton X-100 probed by differential scanning calorimetry and dielectric relaxation spectroscopy.
Merino EG; Rodrigues C; Viciosa MT; Melo C; Sotomayor J; Dionísio M; Correia NT
J Phys Chem B; 2011 Nov; 115(43):12336-47. PubMed ID: 21928821
[TBL] [Abstract][Full Text] [Related]
34. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
Fini A; Cavallari C; Ospitali F
Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
[TBL] [Abstract][Full Text] [Related]
35. Dissolution rate improvement of poorly water-soluble drugs obtained by adsorbing solutions of drugs in hydrophilic solvents onto high surface area carriers.
Friedrich H; Fussnegger B; Kolter K; Bodmeier R
Eur J Pharm Biopharm; 2006 Feb; 62(2):171-7. PubMed ID: 16275049
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of the spontaneous polymorphic transition of pyrazinamide γ form at room temperature by co-spray drying with 1,3-dimethylurea.
Baaklini G; Dupray V; Coquerel G
Int J Pharm; 2015 Feb; 479(1):163-70. PubMed ID: 25556055
[TBL] [Abstract][Full Text] [Related]
37. Molecular dynamics simulation of amorphous indomethacin-poly(vinylpyrrolidone) glasses: solubility and hydrogen bonding interactions.
Xiang TX; Anderson BD
J Pharm Sci; 2013 Mar; 102(3):876-91. PubMed ID: 23280486
[TBL] [Abstract][Full Text] [Related]
38. Processing-induced phase transitions of theophylline--implications on the dissolution of theophylline tablets.
Tantry JS; Tank J; Suryanarayanan R
J Pharm Sci; 2007 May; 96(5):1434-44. PubMed ID: 17455350
[TBL] [Abstract][Full Text] [Related]
39. Effect of drug-carrier interaction on the dissolution behavior of solid dispersion tablets.
Srinarong P; Kouwen S; Visser MR; Hinrichs WL; Frijlink HW
Pharm Dev Technol; 2010; 15(5):460-8. PubMed ID: 20735300
[TBL] [Abstract][Full Text] [Related]
40. Relationship between the crystallization rates of amorphous nifedipine, phenobarbital, and flopropione, and their molecular mobility as measured by their enthalpy relaxation and (1)H NMR relaxation times.
Aso Y; Yoshioka S; Kojima S
J Pharm Sci; 2000 Mar; 89(3):408-16. PubMed ID: 10707020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
